Shriro Holdings Limited provided trading EBITDA guidance for the first six months ending June 2018. For the period, the company expects trading EBITDA is likely to be down around 15% compared with the previous year. However due to higher R&D claims and timing differences, NPAT for this period is expected to be in line with the previous year.